---
schema_version: "secwatch.filing_event.v1"
accession: "0001193125-25-003574"
form_type: "8-K"
ticker: "DBVT"
cik: "0001613780"
company_name: "DBV Technologies S.A."
filed_at: "2025-01-08T23:59:59+00:00"
generated_at: "2026-05-28T06:46:38.259616+00:00"
event_type: "other_material"
sentiment: "positive"
materiality_score: 0.8
calibrated_materiality_score: 0.8
confidence: "high"
source: SEC EDGAR
---

# DBV Technologies reports positive 3-year EPITOPE OLE data; 68.2% passed food challenge at month 36

## Summary
- 68.2% of toddlers completed oral food challenge (~12-14 peanut kernels) without meeting stopping criteria at month 36, vs 30.7% at month 12.
- 83.5% reached eliciting dose ≥1000 mg after three years on Viaskin Peanut, up from 64.2% at month 12.
- No treatment-related anaphylaxis or serious TEAEs occurred in year 3; local application-site reactions decreased vs earlier years.
- New wear-time analysis: subjects with average daily wear time ≥20 hours (68.4% of active group) showed 75.7% responder rate vs 47.3% for <20 hours.
- Data presented at Eastern Food Allergy & Comorbidity Conference; investor webcast on Jan 8, 2025.

## SEC filing metadata
- accession: 0001193125-25-003574
- form_type: 8-K
- ticker: DBVT
- cik: 0001613780
- company_name: DBV Technologies S.A.
- filed_at: 2025-01-08T23:59:59+00:00
- event_type: other_material
- sentiment: positive
- materiality_score: 0.8
- calibrated_materiality_score: 0.8
- confidence: high
- sec_items: 7.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1613780/000119312525003574/0001193125-25-003574-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1613780/000119312525003574/d861550d8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001193125-25-003574
- JSON: https://secwatch.observer/filing/0001193125-25-003574.json
- Plain text: https://secwatch.observer/filing/0001193125-25-003574.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.